Administration
行政
基本信息
- 批准号:8116588
- 负责人:
- 金额:$ 162.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:Annual ReportsBiologicalBiological AssayBudgetsCellsChemicalsCollaborationsCommunicationContract ServicesDevelopment PlansDocumentationFlow CytometryHuman ResourcesIndividualLaboratoriesMolecular TargetParticipantPoliciesPositioning AttributeProceduresProcessProtocols documentationReportingScreening procedureTeleconferencesTrainingUnited States National Institutes of HealthUpdateWorkbaseinnovationmeetingsnoveloperationoutreachsymposiumwikiworking group
项目摘要
ADMINISTRATION/MANAGEMENT CORE (AIM)
A/M Aims 1. Communication (Internal and External). A/M will: i) hold regular Center meetings to discuss
priorities of the Center and use the meetings to update and educate one another regarding activities of the
individual cores; ii) continue our outreach effort, focusing on building collaborations for developing targets
unique to multiplex and/or high content analysis in flow cytometry with a submission of a target for each R03
cycle; iii) organize productive partnerships, in particular those opportunities that allow HT flow cytometry to
reach its potential in novel applications and technological advancement; and iv) if requested by MLPCN,
constitute an Advisory Board to meet in conjunction with our annual Roadmap Symposium in 3rd quarter
(Spring) of each year. Meeting agendas are set with each participant contacted in advance to insure efficient
meeting process. Innovation: Laboratory results and meeting summaries are posted to the Center Wiki.
2. Operations (Budget, Personnel, Reporting to NIH, Co-ordination within UNM). A/M will: i) be responsible for
annual reporting to NIH as well as monthly tracking reports; ii) order and receive SMR shipments and make
these available for screening under the director of the Chemical Biologist in HTS/I; iii) represent the Center at
MLPCN Steering Committee Meetings and insure representation at monthly working group teleconferences.;
iv) organize and prioritize the budget, prepare supplements, manage service contracts; v) prioritize, fill, and
train staff positions in the Center; vi) co-ordinate within UNM regarding human resource policies and
procedures, institutional space policies, etc.
3. Work Flow Management: A/M will: i) organize target teams across the cores; ii) standardize protocols, and
oversee probe development plans, probe and final reports, and other documentation as needed.; and iii)
manage a portfolio of cell and bead-based molecular target assays through the UNMCMD pipeline and
evaluate and implement the overall opportunities of the portfolio for biological impact. Agendas are set for each
target team meeting with each participant contacted in advance to insure efficient meeting process. Meeting
summaries are posted to the Center Wiki.
行政/管理核心(AIM)
A/M目标1.沟通(内部和外部)。A/M将:i)定期召开中心会议,讨论
中心的优先事项,并利用这些会议就中心的活动相互通报和教育
个别核心;二)继续我们的外联努力,重点是为发展目标建立协作
对于流式细胞术中的多重和/或高含量分析来说是独一无二的,需要为每个R03提交一个目标
周期;三)组织富有成效的伙伴关系,特别是那些使HT流式细胞术能够
发挥其在新应用和技术进步方面的潜力;以及iv)如果MLPCN提出要求,
成立一个咨询委员会,与我们在第三季度举行的年度路线图研讨会一起开会
每年的(春天)。设置会议议程,事先联系每个参与者,以确保效率
会议流程。创新:实验室结果和会议摘要发布在维基中心。
2.业务(预算、人事、向国立卫生研究院报告、在联合国监测机制内进行协调)。A/M将:i)负责
向NIH提交年度报告以及每月跟踪报告;ii)订购和接收SMR发货并进行
可在HTS/I的化学生物学家主任的指导下进行筛选;III)代表中心
MLPCN指导委员会的会议,并确保每月工作组电话会议的代表。
四)组织和确定预算的优先顺序,准备补充材料,管理服务合同;五)确定优先顺序,填补和
培训中心的工作人员职位;vi)在UNM内部协调人力资源政策和
程序、机构空间政策等。
3.工作流程管理:A/M将:i)跨核心组织目标团队;ii)标准化协议,以及
根据需要监督探测器开发计划、探测器和最终报告以及其他文档。
管理一系列细胞和基于珠粒的分子靶标分析,通过联合国维和行动的CMD管道和
评估和实施项目组合对生物影响的总体机会。为每个人设置了议程
与事先联系的每位参与者召开目标团队会议,以确保有效的会议过程。会议
摘要发布在维基中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LARRY A. SKLAR其他文献
Differences in fluidity between bilayer halves of plasma cell membranes
浆细胞膜双层两半之间的流动性差异
- DOI:
10.1038/287255b0 - 发表时间:
1980-09-18 - 期刊:
- 影响因子:48.500
- 作者:
LARRY A. SKLAR;MICHAEL C. DOODY - 通讯作者:
MICHAEL C. DOODY
LARRY A. SKLAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LARRY A. SKLAR', 18)}}的其他基金
Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC)
照亮可药物基因组资源传播和外展中心 (IDG-RDOC)
- 批准号:
10532379 - 财政年份:2017
- 资助金额:
$ 162.53万 - 项目类别:
Illuminating the Druggable Genome Resource Dissemination and Outreach Center (IDG-RDOC)
照亮可药物基因组资源传播和外展中心 (IDG-RDOC)
- 批准号:
10314062 - 财政年份:2017
- 资助金额:
$ 162.53万 - 项目类别:
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
新型 DNA 双链断裂修复靶向治疗癌症
- 批准号:
8693254 - 财政年份:2014
- 资助金额:
$ 162.53万 - 项目类别:
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
新型 DNA 双链断裂修复靶向治疗癌症
- 批准号:
8827725 - 财政年份:2014
- 资助金额:
$ 162.53万 - 项目类别:
NOVEL DNA DOUBLE STRAND BREAK REPAIR TARGETING THERAPEUTICS FOR CANCER TREATMENT
新型 DNA 双链断裂修复靶向治疗癌症
- 批准号:
9187077 - 财政年份:2014
- 资助金额:
$ 162.53万 - 项目类别:
University of New Mexico Center for Molecular Discovery
新墨西哥大学分子发现中心
- 批准号:
8443190 - 财政年份:2012
- 资助金额:
$ 162.53万 - 项目类别:
HIGH THROUGHPUT, HIGH CONTENT MOLECULAR LIBRARIES SCREENING
高通量、高内涵分子库筛选
- 批准号:
8361764 - 财政年份:2011
- 资助金额:
$ 162.53万 - 项目类别:
相似海外基金
NSF/BIO-DFG: Biological Fe-S intermediates in the synthesis of nitrogenase metalloclusters
NSF/BIO-DFG:固氮酶金属簇合成中的生物 Fe-S 中间体
- 批准号:
2335999 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Large Language Models for Biological Discoveries (LLMs4Bio)
合作研究:会议:生物发现的大型语言模型 (LLMs4Bio)
- 批准号:
2411529 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Large Language Models for Biological Discoveries (LLMs4Bio)
合作研究:会议:生物发现的大型语言模型 (LLMs4Bio)
- 批准号:
2411530 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
Collaborative Research: NSF-ANR MCB/PHY: Probing Heterogeneity of Biological Systems by Force Spectroscopy
合作研究:NSF-ANR MCB/PHY:通过力谱探测生物系统的异质性
- 批准号:
2412551 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
Elucidating mechanisms of biological hydrogen conversion through model metalloenzymes
通过模型金属酶阐明生物氢转化机制
- 批准号:
2419343 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
Collaborative Research: The Interplay of Water Condensation and Fungal Growth on Biological Surfaces
合作研究:水凝结与生物表面真菌生长的相互作用
- 批准号:
2401507 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
DESIGN: Driving Culture Change in a Federation of Biological Societies via Cohort-Based Early-Career Leaders
设计:通过基于队列的早期职业领袖推动生物协会联盟的文化变革
- 批准号:
2334679 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
REU Site: Modeling the Dynamics of Biological Systems
REU 网站:生物系统动力学建模
- 批准号:
2243955 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Standard Grant
Defining the biological boundaries to sustain extant life on Mars
定义维持火星现存生命的生物边界
- 批准号:
DP240102658 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Discovery Projects
Advanced Multiscale Biological Imaging using European Infrastructures
利用欧洲基础设施进行先进的多尺度生物成像
- 批准号:
EP/Y036654/1 - 财政年份:2024
- 资助金额:
$ 162.53万 - 项目类别:
Research Grant














{{item.name}}会员




